ArticleScientific reports2025

SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer.

Lutfi H Alfarsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.